SO
HRMY icon

STRS Ohio’s Harmony Biosciences HRMY Stock Holding History

STRS Ohio’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Sell
6,100
-14,700
-71% -$464K ﹤0.01% 1549
2026
Q1 		$583K Buy
20,800
+6,200
+42% +$203K ﹤0.01% 986
2025
Q4 		$546K Sell
14,600
-4,400
-23% -$145K ﹤0.01% 1018
2025
Q3 		$524K Hold
19,000
– – ﹤0.01% 1068
2025
Q2 		$600K Buy
19,000
+1,300
+7% +$41.8K ﹤0.01% 1132
2025
Q1 		$587K Sell
17,700
-900
-5% -$32.3K ﹤0.01% 1090
2024
Q4 		$640K Hold
18,600
– – ﹤0.01% 1034
2024
Q3 		$744K Sell
18,600
-2,300
-11% -$80.8K ﹤0.01% 1022
2024
Q2 		$631K Hold
20,900
– – ﹤0.01% 1072
2024
Q1 		$701K Buy
+20,900
New +$671K ﹤0.01% 1052
2023
Q1 		– Sell
-5,600
Closed -$308K – 1996
2022
Q4 		$308K Buy
+5,600
New +$308K ﹤0.01% 1489
2021
Q4 		– Sell
-1,100
Closed -$42K – 2247
2021
Q3 		$42K Sell
1,100
-400
-27% -$12.9K ﹤0.01% 2095
2021
Q2 		$42K Hold
1,500
– – ﹤0.01% 2128
2021
Q1 		$49K Hold
1,500
– – ﹤0.01% 2028
2020
Q4 		$54K Buy
+1,500
New +$60.5K ﹤0.01% 1981

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

STRS Ohio's HRMY Position: Q2 2026 in Review

STRS Ohio reduced its Harmony Biosciences (HRMY) stake by 71% in Q2 2026, selling an estimated $464K and leaving 6,100 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

STRS Ohio first reported a position in HRMY in Q4 2020 and has held it in 15 quarters since. The position peaked at $744K in Q3 2024. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • STRS Ohio held 6,100 shares of Harmony Biosciences worth $222K as of Q2 2026.
  • STRS Ohio sold 14,700 Harmony Biosciences shares in Q2 2026, an estimated $464K.
  • Harmony Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1549 holding.
  • STRS Ohio first reported a position in Harmony Biosciences in Q4 2020 and has held it in 15 quarters since.
  • STRS Ohio's Harmony Biosciences position peaked at $744K in Q3 2024.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.